In these networks, RHO, PDE6A, 3′,5′-cyclic-GMP phosphodiesterase, and G protein alpha were in the central “nodes,” which prompt their roles as the target genes for AMD treatment. The gene discussed is PDE6A; the disease is age-related macular degeneration.